Citation: Mj. Postma et al., Cost-effectiveness analysis of pneumococcal vaccination for elderly individuals in the Netherlands, PHARMACOECO, 19(2), 2001, pp. 215-222
Authors:
Bos, JM
Rumke, HC
Welte, R
Postma, MJ
Jager, JC
Citation: Jm. Bos et al., Health economics of a hexavalent meningococcal outer-membrane vesicle vaccine in children: potential impact of introduction in the Dutch vaccination program, VACCINE, 20(1-2), 2001, pp. 202-207
Authors:
Postma, MJ
Baltussen, RMPM
Heijnen, MLA
de Jong-van den Berg, LTW
Jager, JC
Citation: Mj. Postma et al., Pharmacoeconomics of influenza vaccination in the elderly - Reviewing the available evidence, DRUG AGING, 17(3), 2000, pp. 217-227
Authors:
Downs, AM
Heisterkamp, SH
Rava, L
Houweling, H
Jager, JC
Hamers, FF
Citation: Am. Downs et al., Back-calculation by birth cohort, incorporating age-specific disease progression, pre-AIDS mortality and change in European AIDS case definition, AIDS, 14(14), 2000, pp. 2179-2189
Authors:
Welte, R
Kretzschmar, M
Leidl, R
Van den Hoek, A
Jager, JC
Postma, MJ
Citation: R. Welte et al., Cost-effectiveness of screening programs for Chlamydia trachomatis - A population-based dynamic approach, SEX TRA DIS, 27(9), 2000, pp. 518-529
Authors:
Postma, MJ
Beck, EJ
Mandalia, S
Sherr, L
Walters, MDS
Houweling, H
Jager, JC
Citation: Mj. Postma et al., Universal HIV screening of pregnant women in England: cost effectiveness analysis, BR MED J, 318(7199), 1999, pp. 1656-1660
Authors:
Rutten-van Molken, MPMH
Postma, MJ
Joore, MA
Van Genugten, MLL
Leidl, R
Jager, JC
Citation: Mpmh. Rutten-van Molken et al., Current and future medical costs of asthma and chronic obstructive pulmonary disease in the Netherlands, RESP MED, 93(11), 1999, pp. 779-787